| Product Code: ETC6188946 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The posterior segment eye disorders market in Australia is growing due to increasing cases of retinal diseases and macular degeneration. Advanced diagnostic techniques and innovative treatments such as anti-VEGF therapy are driving market growth.
The posterior segment eye disorders market in Australia is growing due to increasing cases of age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. Rising elderly population, increasing prevalence of diabetes, and growing awareness about early diagnosis and treatment are key market drivers. Advances in intravitreal injections, anti-VEGF therapies, and laser treatments are supporting market growth. Government support for eye health programs and increased access to specialized ophthalmic care are also contributing to market expansion.
The posterior segment eye disorders market in Australia is constrained by high drug development and clinical trial costs. Regulatory requirements for ophthalmic drug safety and patient care increase production complexity. Competition from alternative treatments and limited patient access to specialized eye care reduce market demand. High costs of surgical interventions further restrict market growth.
The posterior segment eye disorders market in Australia is growing due to increasing cases of macular degeneration and diabetic retinopathy. Investment opportunities exist in developing advanced drug delivery systems, gene therapy, and AI-based diagnostic platforms. Expanding access to ophthalmology services in rural areas presents additional potential.
Government policies in the healthcare sector support the treatment of posterior segment eye disorders through Medicare and the PBS, which cover diagnostic tests and medications for conditions like macular degeneration and diabetic retinopathy. Funding for ophthalmology research and infrastructure is provided under the Medical Research Future Fund (MRFF). Regulations ensure that new treatments meet safety and efficacy standards before market approval.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Posterior Segment Eye Disorders Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Posterior Segment Eye Disorders Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Posterior Segment Eye Disorders Market - Industry Life Cycle |
3.4 Australia Posterior Segment Eye Disorders Market - Porter's Five Forces |
3.5 Australia Posterior Segment Eye Disorders Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Posterior Segment Eye Disorders Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Aging population in Australia leading to a higher prevalence of posterior segment eye disorders |
4.2.2 Technological advancements in diagnostic tools and treatment options for posterior segment eye disorders |
4.2.3 Increasing awareness about eye health and early detection of eye diseases |
4.3 Market Restraints |
4.3.1 High treatment costs associated with advanced therapies for posterior segment eye disorders |
4.3.2 Limited access to specialized eye care services in rural and remote areas of Australia |
5 Australia Posterior Segment Eye Disorders Market Trends |
6 Australia Posterior Segment Eye Disorders Market, By Types |
6.1 Australia Posterior Segment Eye Disorders Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Australia Posterior Segment Eye Disorders Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Australia Posterior Segment Eye Disorders Market Revenues & Volume, By Macular Degeneration, 2021- 2031F |
6.1.4 Australia Posterior Segment Eye Disorders Market Revenues & Volume, By Glaucoma, 2021- 2031F |
6.1.5 Australia Posterior Segment Eye Disorders Market Revenues & Volume, By Diabetic Retinopathy, 2021- 2031F |
6.1.6 Australia Posterior Segment Eye Disorders Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Posterior Segment Eye Disorders Market Import-Export Trade Statistics |
7.1 Australia Posterior Segment Eye Disorders Market Export to Major Countries |
7.2 Australia Posterior Segment Eye Disorders Market Imports from Major Countries |
8 Australia Posterior Segment Eye Disorders Market Key Performance Indicators |
8.1 Average wait time for patients to receive treatment for posterior segment eye disorders |
8.2 Number of ophthalmologists specializing in posterior segment eye disorders per capita in Australia |
8.3 Patient satisfaction rates with the quality of care and treatment outcomes for posterior segment eye disorders |
9 Australia Posterior Segment Eye Disorders Market - Opportunity Assessment |
9.1 Australia Posterior Segment Eye Disorders Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Posterior Segment Eye Disorders Market - Competitive Landscape |
10.1 Australia Posterior Segment Eye Disorders Market Revenue Share, By Companies, 2024 |
10.2 Australia Posterior Segment Eye Disorders Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here